S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Better Than Oil Stocks (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
NASDAQ:SMMT

Summit Therapeutics (SMMT) Earnings Date, Estimates & Call Transcripts

$1.87
+0.04 (+2.19%)
(As of 09/29/2023 ET)
Compare
Today's Range
$1.82
$1.89
50-Day Range
$1.54
$2.12
52-Week Range
$0.66
$5.78
Volume
584,517 shs
Average Volume
864,940 shs
Market Capitalization
$1.30 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Earnings Summary

Upcoming
Earnings Date
Nov. 8Estimated
Actual EPS
(Aug. 9)
-$0.02 Missed By -$0.02
Skip Charts & View Estimated and Actual Earnings Data

SMMT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SMMT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

SMMT Earnings Date and Information

Summit Therapeutics last announced its quarterly earnings results on August 9th, 2023. The reported ($0.02) earnings per share for the quarter. Summit Therapeutics has generated ($1.66) earnings per share over the last year (($1.66) diluted earnings per share). Summit Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off prior year's report dates.

Summit Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/8/2023
Estimated)
------- 
8/9/2023Q2 2023-($0.02)($0.02)($0.02)--
5/11/2023Q1 2023-($0.06)($0.06)$1.31--  
3/9/2023Q4 2022-($0.07)($0.07)($0.07)-$1.13 million
11/9/2022Q3 2022-($0.14)($0.14)($0.14)-$5.68 million
8/11/2022Q2 2022-($0.17)($0.17)($0.17)-$3.25 million
5/11/2022Q1 2022-($0.22)($0.22)($0.22)-$5.06 million
3/17/2022Q4 2021-($0.28)($0.28)($0.28)-$4.84 million
11/15/2021Q3 2021($0.29)($0.20)+$0.09($0.20)-$6.12 million
8/11/2021Q2 2021($0.18)($0.27)($0.09)($0.27)$4.45 million$6.18 million
5/17/2021Q1 2021($0.17)($0.21)($0.04)($0.21)$4.41 million$5.64 million
3/17/2021Q4 2020($0.21)($0.18)+$0.03($0.18)$4.53 million$4.55 million
11/15/2020Q3 2020($0.24)($0.26)($0.02)($0.24)$4.08 million$4.49 million  
10/4/2020Q2 2020($0.02)($1.15)($1.13)($0.23)$4.05 million$0.17 million












Summit Therapeutics Earnings - Frequently Asked Questions

When is Summit Therapeutics's earnings date?

Summit Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 8th, 2023 based off last year's report dates. Learn more on SMMT's earnings history.

How much revenue does Summit Therapeutics generate each year?

Summit Therapeutics (NASDAQ:SMMT) has a recorded annual revenue of $700,000.00.

How much profit does Summit Therapeutics generate each year?

Summit Therapeutics (NASDAQ:SMMT) has a recorded net income of -$78.78 million. SMMT has generated -$1.66 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:SMMT) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -